Tasca

Boston, United States

Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.

$52.0M raised

Dec 2024

Series A

Top Investors

InvusCure VenturesRegeneron Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Tasca raised?

Tasca has raised $52.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.

Who are Tasca's investors?

Tasca's investors include Invus, Cure Ventures, Regeneron Ventures.

Where is Tasca headquartered?

Tasca is headquartered in Boston, United States.

What does Tasca do?

Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.

What stage is Tasca at?

Tasca is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 10, 2024.

MLA

"Tasca — Funding & Investors." VCBacked, December 10, 2024, https://www.vcbacked.co/company/tasca. Accessed June 3, 2026.

APA

VCBacked. (2024). Tasca — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/tasca

Wikipedia (cite web)

{{cite web |title=Tasca — Funding & Investors |url=https://www.vcbacked.co/company/tasca |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 10, 2024.